Counterfeit and unapproved COVID-19 products continue to be seized by CBP.

U.S. Customs and Border Protection (CBP) continues to seize many shipments of counterfeit, unapproved or other COVID-19 products of questionable quality.

At the beginning of June 2020, CBP has seized the following COVID-19 related items:

107,300 FDA-prohibited COVID-19 test kits in 301 incidents;
750,000 counterfeit face masks in 86 incidents;
2,500 EPA-prohibited anti-virus lanyards in 89 incidents; and
11,000 FDA-prohibited chloroquine tablets in 91 incidents.

In addition to the risk of using non-FDA approved drugs, CBP claims the sale of counterfeit COVID-19 goods benefit organized crime.

If you have had your shipment seized by Customs, contact seizure attorney David Hsu by phone/text at anytime to 832-896-6288 or contact us by email at attorney.dave@yahoo.com.

Chinese-made COVID-19 treatment drugs seized by Customs.

Lianhua Qingwen Capsules from China, source: CBP.gov

While coverage of the George Floyd dominates the airwaves, many people are still concerned about COVID-19 as evidenced by the continued importation of COVID-19 treatment drugs from China.

Specifically, earlier this month, U.S. Customs and Border Protection (CBP) officers in Mississippi seized two shipments containing more than 2,000 “Lianhua Qingwen” capsules and “balangen” granules. These two drugs have been touted as treating COVID-19 symptoms.

Customs has seized multiple shipments of these two named drugs and CBP tests reveal the drugs contain sugar and iron. As these drugs do not have FDA approval, they were seized by CBP and will likely be destroyed. The FDA prohibits importation of food, drug, device, tobacco or cosmetic products that are undeclared, misbranded or misnamed. As a rresult, CBP seized the unapproved drugs as they have not been tested and may cause harm or death to US citizens.

Lainhua Qingwen capsules and granules are sold in China and elsewhere in Asia as treating COVID-19 symptoms.

If you have had a Customs seizure, contact David Hsu 24/7 by phone/text to 832-896-6288 or by email at attorney.dave@yahoo.com,

Unauthorized COVID-19 medicine seized.

Seized COVID-19 medicine, source: CBP.gov

U.S. Customs and Border Protection (CBP) officers seized 360 pills of medicine marketed to treating COVID-19. The medicine was a violation of U.S. Food and Drug Administration (FDA) rules preventing unauthorized medical treatments that may mislead consumers by making false claims to prevent or treat diseases or may in fact harm the consumer.

The FDA is especially concerned with unauthorized COVID-19 treatments that are marketed towards curing, treating or preventing serious illnesses.

If you have had your good seized by Customs, contact seizure attorney David Hsu by phone/text at 832-896-6288 or by email at attorney.dave@yahoo.com.

Customs seizes Chinese medication for treatment of COVID-19.

pills

Image of seized pills, source: CBP.gov

U.S. Customs and Border Protection (CBP) officers at the O’Hare International Airport international mail facility seized medication from China. The medication made claims it could treat COVID-19, violating FDA laws and therefore seized by CBP. CBP seized a total of 9,600 capsules of “Lianhua Qingwen Jiaonang”. According to various sources online, Lianhua Qingwen Jiaonang is a combination of dozens of herbs in capsule form. According to CBP, the shipment contained an estimated value of $28,797.

If you have had your good seized by Customs, contact customs seizure attorney David Hsu by phone/text at 832-896-6288 or by email at attorney.dave@yahoo.com.

CBP seizes counterfeit protective equipment and medications.

HAR COVID Rx6L 042120

Image of seized medication, source: CBP.gov

U.S. Customs and Border Protection (CBP) officers seize shipments of counterfeit personal protective equipment (PPE) and medications to treat the corona virus.

Since late March and the height of the corona virus panemdic, CBP has seized, including but not limited to:

-1,200 “Linhua Qingwen” capsules that are not approved by the FDA for medicine in treatment of COVID-19.
-1,350 counterfeit test kits
-400 counterfeit N95 masks
-2,500 possibly counterfeit medicine such as Hydroxychloroquine Sulfate, Chloroquine, Azithromycin, Lianhua Qingwen and Liushen Jiaonang; and
-67,000 counterfeit ACCU-CHEK test strips.

If you have questions about your shipment seized by Customs and you want a free, no cost or obligation consultation, contact by phone/text David Hsu at anytime: 832-896-6288 or by email at attorney.dave@yahoo.com.

IAD 354 COVID Masks2L 040320

Image of seized masks, source: cbp.gov

Fake Cialis and Viagra Pills Seized by CBP.

Counterfiet Cialis 1

Counterfeit medication from Turkey; source: CBP.gov

U.S. Customs and Border Protection (CBP) officers in Kentucky seized counterfeit Cialis and Viagra pills in Kentucky. The shipment from Turkey was destined to a city in California and labeled as “throat lozenges and candies”. However, CBP’s experienced officers looked at the totality of the circumstances and determined the route of the shipment and the packaging of the pills were indicative of being counterfeit pills.

Customs warns consumers of the dangers of buying counter medicines – which may have the incorrect or harmful ingredients.

If you have had your shipment seized by Customs, contact customs seizure attorney David Hsu by phone/text at anytime at 832-896-6288 or by email at attorney.dave@yahoo.com.

More counterfeit COVID-19 test kits seized.

Test Kit 1

Image of seized COVID-19 test kit, source: CBP.gov

U.S. Customs and Border Protection (CBP) officers in New Jersey seized another shipment containing counterfeit COVID-19 test kits. A secondary inspection of the shipment discovered 25 COVID-19 test kits not approved by the U.S. Food and Drug Administration (FDA). This seizure was just 25 out of the 600 COVID test kits seized at the Rochester airport.

All imported test kits are presumed to lack FDA approval as the FDA has only allowed 50 companies to develop and distribute the COVID test kits and the companies that manufactured the seized test kits have not been approved.

*****

My guess for the large number of imports and seizures of the test kits are due to family members overseas sending kits to their family in the US who want to be sure they do not have the virus and pass on to older family members.

If you have had your good seized by customs and want to know what you can do next, contact experienced seizure attorney David Hsu by phone at 832-896-6288 or by email at attorney.dave@yahoo.com.

35 pounds of counterfeit Xanax seized by Customs.

Xanax 2

Image of seized Xanax, source: CBP.gov

Last week, U.S. Customs and Border Protection (CBP) officers in the Champlain Port of Entry seized 35 pounds of counterfeit Xanax among 27 shipments.

The shipments were unlabeled pills but resembled the anxiety drug. Afterwards, CBP sent the pills for testing and were determined to contain the properties of Xanax. As Xanax is a schedule 4 controlled substance and cannot be shipped to the US without a prescription.

If you have had your shipment seized, contact David Hsu for a free consultation by phone/text at 832-896-6288 or by email at attorney.dave@yahoo.com.

CBP seizes non-FDA compliant thermometers.

pexels-photo-3987148

Photo by Anna Shvets on Pexels.com

According to a U.S. Customs and Border Protection media release, CBP officers in El Paso’s Bridge of the America’s facility seized a shipment of “pyrometers” (infrared forehead thermometers) with a value of over $7,000.

Upon examination, the CBP officers found the pyrometers to be non-compliant with FDA regulations. It is important for FDA compliance on these types of thermometers because they can give false readings if they do not meet strict FDA requirements.

If you have had your goods seized for non-FDA compliance, or if you have any questions about ensuring FDA compliance BEFORE you import, contact experienced import and export attorney David Hsu at 832-896-6288 or by email at attorney.dave@yahoo.com.

New CSMS message about importing personal protective equipment during the COVID-19 public health emergency.

pexels-photo-3962293

Photo by Anna Shvets on Pexels.com

Due to the COVID-19 health crisis and to help facilitate the importation of personal protective equipment (PPE), the FDA issued new instructions for PPE and medical devices through the Cargo Systems Messaging Service. A copy and paste of the entire message is copied below:


CSMS #42124872 -Information for Filing Personal Protective Equipment and Medical Devices During COVID-19

The U.S. Food and Drug Administration is providing instruction to the import community regarding the submission of entry information for personal protective equipment and certain other devices. Following the instructions below will help facilitate the import process for all; especially for products related to the Coronavirus Disease-2019 (COVID-19) public health emergency. It is in the best interest of the U.S. to facilitate and expedite the importation of products into the U.S. market that address immediate, urgent public health needs.

For further information regarding entry submission requirements, see the FDA Supplemental Guidance for ACE at https://www.cbp.gov/sites/default/files/assets/documents/2020-Mar/FDA%20Supplemental%20Guide%20Release%202.5.1%202018%200410.pdf.

1. Non-FDA-regulated general purpose personal protective equipment (masks, respirators, gloves, etc.):

Personal protective equipment for general purpose or industrial use (that is, products that are not intended for use to prevent disease or illness) is not regulated by FDA.

For these types of products, entry information should not be transmitted to FDA. At the time of entry for these products, Importers should transmit entry information to US Customs and Border Protection (CBP) using an appropriate HTS code with no FD Flag; or using an appropriate HTS code with an FD1 flag and do a ‘disclaim’ for FDA.

2. Products authorized for emergency use pursuant to an Emergency Use Authorization (EUA)

When importing such products, entry information should be submitted to FDA; however reduced FDA information is required for review.

At the time of entry, Importers should transmit an Intended Use Code of 940.000: Compassionate Use/Emergency Use, and an appropriate FDA product code.

Below is a list of products and the appropriate product codes that are currently authorized by an EUA:

• Diagnostic tests: QPK, OTG, QKO, QJR
• Masks/Respirators: NZJ

Questions regarding appropriate product coding can be submitted to FDA at: COVID19FDAIMPORTINQUIRIES@fda.hhs.gov.

Requests for Emergency Use Authorization can be submitted to FDA at: CDRH-EUA-Templates@fda.hhs.gov (for diagnostic devices) and CDRH-NonDiagnosticEUA-Templates@fda.hhs.gov (for non-diagnostic devices)

3. Products regulated by FDA as a device, not authorized by an EUA, but where an enforcement discretion policy has been published in guidance.

When importing such devices, entry information should be submitted to FDA.

At the time of entry, Importers should transmit an Intended Use Code of 081.006: Enforcement discretion per final guidance, and an appropriate FDA product code.

Below is a listing of guidance documents that have been issued for specific products related to COVID-19, which contain product codes within the scope of each guidance:

• Non-Invasive Remote Monitoring Devices
• Ventilators and Accessories and Other Respiratory Devices

A full list of all guidance documents related to COVID-19 is also available on FDA’s website.

All questions regarding these instructions, or to resolve entry issues for shipments can be submitted to FDA at: COVID19FDAIMPORTINQUIRIES@fda.hhs.gov or 301-796-0356.


If you import PPE and have any questions, please do not hesitate to contact experienced trade attorney David Hsu by phone/text at 832-896-6288 or by email at attorney.dave@yahoo.com.